You have 9 free searches left this month | to do more

mgcd0103

Mgcd0103 is a drug used to treat Myelodysplastic Syndromes, Leukemia, Tumors, and other conditions. Mgcd0103 is not being actively studied and prior, has been studied in 7.

Top SponsorsTop SitesTop Investigators
Mirati Therapeutics Inc.MD Anderson Cancer Center
Gabrail Cancer Center
Princess Margaret Hospital
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Terminated
  • Hodgkin's Lymphoma
  • MGCD0103
  • Chicago, Illinois
  • +4 more
2015-06-05
Jun 5, 2015
M
Completed
  • Lymphoma
  • MGCD0103
  • Durham, North Carolina
  • +4 more
2015-06-04
Jun 4, 2015
M
Completed
  • Tumors
  • Indianapolis, Indiana
  • +7 more
2015-06-04
Jun 4, 2015
M
Completed
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • MGCD0103
  • Los Angeles, California
  • +7 more
2015-06-04
Jun 4, 2015
M
Completed
  • Lymphocytic Leukemia, Chronic
  • MGCD0103
  • Kansas City, Missouri
  • +12 more
2015-06-04
Jun 4, 2015
M
Terminated
  • Myelogenous Leukemia, Acute
  • Myelodysplastic Syndromes
  • MGCD0103
  • Kansas City, Missouri
  • +12 more
2015-06-04
Jun 4, 2015
M
Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • MGCD0103
  • Houston, Texas
  • +2 more
2015-01-06
Jan 6, 2015
M
Completed
  • Tumors
  • Non Hodgkin's Lymphoma
  • MGCD0103
  • Baltimore, Maryland
  • +2 more
2015-01-06
Jan 6, 2015
M
Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • MGCD0103
  • Tampa, Florida
  • +3 more
2015-01-06
Jan 6, 2015